Aichi-ken, Japan

Yoshinobu Hashizume




Average Co-Inventor Count = 8.3

ph-index = 4

Forward Citations = 56(Granted Patents)


Location History:

  • Aichi-Ken, JP (2004 - 2008)
  • Chita-gun, JP (2009)

Company Filing History:


Years Active: 2004-2009

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Yoshinobu Hashizume

Introduction

Yoshinobu Hashizume is a notable inventor based in Aichi-ken, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address various medical conditions. With a total of 5 patents, his work has garnered attention for its potential therapeutic applications.

Latest Patents

One of Hashizume's latest patents involves aryl or heteroaryl fused imidazole compounds that serve as anti-inflammatory and analgesic agents. This invention provides a compound formula that includes various elements, making it useful for treating medical conditions mediated by prostaglandins, such as pain, fever, or inflammation. Additionally, he has developed alpha aryl or heteroaryl methyl beta piperidino propanamide compounds that act as ORL1-receptor antagonists. These compounds are designed to treat diseases or conditions like pain and various CNS diseases.

Career Highlights

Throughout his career, Yoshinobu Hashizume has worked with prominent companies in the pharmaceutical industry, including Pfizer Corporation and Raqualia Pharma Inc. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.

Collaborations

Hashizume has collaborated with notable colleagues such as Kazunari Nakao and Yoshiyuki Okumura. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Yoshinobu Hashizume's innovative work in pharmaceuticals highlights his commitment to addressing critical medical needs through his inventions. His contributions continue to pave the way for advancements in treatment options for various health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…